
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $547.5M | $623.7M | $653.9M | $689.2M | $719.2M | |
Revenue Growth (YoY) | -9.76% | 13.91% | 4.84% | 5.4% | 4.35% | |
Cost of Revenues | $101.5M | $114.2M | $115M | $122.2M | $124.3M | |
Gross Profit | $446M | $509.5M | $538.9M | $567M | $594.8M | |
Gross Profit Margin | 81.46% | 81.69% | 82.42% | 82.27% | 82.71% | |
R&D Expenses | -- | $77.3M | $89M | $99.6M | $113.9M | |
Selling, General & Admin | $303.2M | $281.9M | $289.5M | $312.3M | $320.2M | |
Other Inc / (Exp) | -$928.1M | -$126K | -$8.1M | -$3.6M | $40.6M | |
Operating Expenses | $416.4M | $461.1M | $472.9M | $512.9M | $541.3M | |
Operating Income | $29.5M | $48.3M | $66M | $54.1M | $53.5M | |
Net Interest Expenses | $37.9M | $38.7M | $35.3M | $32.4M | $32.2M | |
EBT. Incl. Unusual Items | -$936.4M | $9.5M | $22.6M | $18.1M | $61.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$119.3M | -$1.3M | $5.4M | -$100.3M | $13.7M | |
Net Income to Company | -$817.1M | $10.8M | $17.2M | $118.4M | $48.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$817.1M | $10.8M | $17.2M | $118.4M | $48.2M | |
Basic EPS (Cont. Ops) | -$12.15 | $0.16 | $0.25 | $1.77 | $0.73 | |
Diluted EPS (Cont. Ops) | -$12.15 | $0.15 | $0.25 | $1.74 | $0.72 | |
Weighted Average Basic Share | $67.2M | $68.7M | $68.2M | $66.7M | $66M | |
Weighted Average Diluted Share | $67.2M | $71.3M | $69.6M | $68.2M | $67.4M | |
EBITDA | -$785.3M | $150.1M | $152.3M | $151.5M | $201.2M | |
EBIT | -$898.6M | $48.2M | $57.9M | $50.5M | $94.1M | |
Revenue (Reported) | $547.5M | $623.7M | $653.9M | $689.2M | $719.2M | |
Operating Income (Reported) | $29.5M | $48.3M | $66M | $54.1M | $53.5M | |
Operating Income (Adjusted) | -$898.6M | $48.2M | $57.9M | $50.5M | $94.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $153.3M | $158.2M | $167.1M | $180.2M | $179M | |
Revenue Growth (YoY) | 3.51% | 3.2% | 5.6% | 7.85% | -0.64% | |
Cost of Revenues | $27.8M | $27.8M | $29.8M | $30M | $30.9M | |
Gross Profit | $125.5M | $130.5M | $137.3M | $150.2M | $148.1M | |
Gross Profit Margin | 81.85% | 82.46% | 82.17% | 83.37% | 82.72% | |
R&D Expenses | -- | $21.3M | $24.1M | $28.1M | $28.5M | |
Selling, General & Admin | $83.2M | $73.7M | $76.6M | $82M | $86.1M | |
Other Inc / (Exp) | $38K | $208K | $8.2M | -$3.6M | -$25K | |
Operating Expenses | $108.9M | $119.5M | $124.7M | $137.5M | $141.6M | |
Operating Income | $16.5M | $10.9M | $12.5M | $12.7M | $6.5M | |
Net Interest Expenses | $10M | $9.3M | $8.2M | $8.3M | $7.7M | |
EBT. Incl. Unusual Items | $6.6M | $1.8M | $12.5M | $820K | -$1.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.3M | -$2.5M | $1M | $36K | $780K | |
Net Income to Company | $5.3M | $4.3M | $11.5M | $784K | -$2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.3M | $4.3M | $11.5M | $784K | -$2M | |
Basic EPS (Cont. Ops) | $0.08 | $0.06 | $0.17 | $0.01 | -$0.03 | |
Diluted EPS (Cont. Ops) | $0.08 | $0.06 | $0.17 | $0.01 | -$0.03 | |
Weighted Average Basic Share | $67.8M | $69.5M | $66.5M | $66.3M | $64.5M | |
Weighted Average Diluted Share | $70.3M | $70.9M | $67.7M | $67.3M | $64.5M | |
EBITDA | $42.3M | $35.7M | $44.8M | $36.5M | $33.5M | |
EBIT | $16.6M | $11.1M | $20.8M | $9.1M | $6.4M | |
Revenue (Reported) | $153.3M | $158.2M | $167.1M | $180.2M | $179M | |
Operating Income (Reported) | $16.5M | $10.9M | $12.5M | $12.7M | $6.5M | |
Operating Income (Adjusted) | $16.6M | $11.1M | $20.8M | $9.1M | $6.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $552.7M | $628.6M | $662.7M | $702.3M | $718M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $103.3M | $114.1M | $117M | $122.4M | $125.3M | |
Gross Profit | $449.4M | $514.5M | $545.7M | $579.9M | $592.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $91.8M | $103.6M | $114.3M | |
Selling, General & Admin | $302.5M | $272.3M | $292.4M | $317.7M | $324.3M | |
Other Inc / (Exp) | -$6.3M | $44K | -$109K | -$15.4M | $44.1M | |
Operating Expenses | $410.5M | $471.7M | $478.1M | $525.6M | $545.5M | |
Operating Income | $38.9M | $42.7M | $67.6M | $54.3M | $47.2M | |
Net Interest Expenses | $40.3M | $38.1M | $34.2M | $32.5M | $31.5M | |
EBT. Incl. Unusual Items | -$7.7M | $4.7M | $33.3M | $6.4M | $59.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $16.7M | -$5.1M | $8.9M | -$101.3M | $14.4M | |
Net Income to Company | -$24.4M | $9.9M | $24.3M | $107.7M | $45.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$24.4M | $9.9M | $24.3M | $107.7M | $45.4M | |
Basic EPS (Cont. Ops) | -$0.36 | $0.10 | $0.36 | $1.62 | $0.69 | |
Diluted EPS (Cont. Ops) | -$0.37 | $0.08 | $0.36 | $1.57 | $0.68 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $140.6M | $143.6M | $161.4M | $143.2M | $198.2M | |
EBIT | $32.6M | $42.8M | $67.5M | $38.9M | $91.4M | |
Revenue (Reported) | $552.7M | $628.6M | $662.7M | $702.3M | $718M | |
Operating Income (Reported) | $38.9M | $42.7M | $67.6M | $54.3M | $47.2M | |
Operating Income (Adjusted) | $32.6M | $42.8M | $67.5M | $38.9M | $91.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $153.3M | $158.2M | $167.1M | $180.2M | $179M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $27.8M | $27.8M | $29.8M | $30M | $30.9M | |
Gross Profit | $125.5M | $130.5M | $137.3M | $150.2M | $148.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $21.3M | $24.1M | $28.1M | $28.5M | |
Selling, General & Admin | $83.2M | $73.7M | $76.6M | $82M | $86.1M | |
Other Inc / (Exp) | $38K | $208K | $8.2M | -$3.6M | -$25K | |
Operating Expenses | $108.9M | $119.5M | $124.7M | $137.5M | $141.6M | |
Operating Income | $16.5M | $10.9M | $12.5M | $12.7M | $6.5M | |
Net Interest Expenses | $10M | $9.3M | $8.2M | $8.3M | $7.7M | |
EBT. Incl. Unusual Items | $6.6M | $1.8M | $12.5M | $820K | -$1.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.3M | -$2.5M | $1M | $36K | $780K | |
Net Income to Company | $5.3M | $4.3M | $11.5M | $784K | -$2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $5.3M | $4.3M | $11.5M | $784K | -$2M | |
Basic EPS (Cont. Ops) | $0.08 | $0.06 | $0.17 | $0.01 | -$0.03 | |
Diluted EPS (Cont. Ops) | $0.08 | $0.06 | $0.17 | $0.01 | -$0.03 | |
Weighted Average Basic Share | $67.8M | $69.5M | $66.5M | $66.3M | $64.5M | |
Weighted Average Diluted Share | $70.3M | $70.9M | $67.7M | $67.3M | $64.5M | |
EBITDA | $42.3M | $35.7M | $44.8M | $36.5M | $33.5M | |
EBIT | $16.6M | $11.1M | $20.8M | $9.1M | $6.4M | |
Revenue (Reported) | $153.3M | $158.2M | $167.1M | $180.2M | $179M | |
Operating Income (Reported) | $16.5M | $10.9M | $12.5M | $12.7M | $6.5M | |
Operating Income (Adjusted) | $16.6M | $11.1M | $20.8M | $9.1M | $6.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $67.7M | $39.1M | $31.7M | $39.2M | $50.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $93.6M | $98.9M | $107.9M | $125.4M | $133.7M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $6.5M | $7.8M | $8.4M | $12.6M | $13.8M | |
Other Current Assets | $10.2M | $1.7M | $605K | $1.3M | $16.1M | |
Total Current Assets | $178.1M | $147.4M | $148.6M | $178.4M | $214.3M | |
Property Plant And Equipment | $41.3M | $43M | $45.2M | $43.9M | $40.7M | |
Long-Term Investments | $21.1M | $21.1M | $21M | $21M | -- | |
Goodwill | -- | $26.2M | $102.9M | $147.1M | $143.3M | |
Other Intangibles | $835.2M | $769.4M | $707.1M | $669.2M | $585.7M | |
Other Long-Term Assets | -- | -- | -- | $21M | $27.3M | |
Total Assets | $1.1B | $1B | $1B | $1.2B | $1.1B | |
Accounts Payable | $16.5M | $15.4M | $18.2M | $22.3M | $33.5M | |
Accrued Expenses | $47.8M | $46.3M | $54.3M | $68.7M | $47.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $90.4M | $94.3M | $106M | $145.7M | $116.9M | |
Long-Term Debt | $576.1M | $457.4M | $458.2M | $460.1M | $455.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $735.5M | $609.2M | $640.4M | $680.3M | $600.4M | |
Common Stock | $674K | $692K | $662K | $659K | $643K | |
Other Common Equity Adj | -$6.8M | -$2M | -- | $951K | -$1.6M | |
Common Equity | $340.2M | $398M | $384.4M | $492.1M | $511.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $340.2M | $398M | $384.4M | $492.1M | $511.5M | |
Total Liabilities and Equity | $1.1B | $1B | $1B | $1.2B | $1.1B | |
Cash and Short Terms | $67.7M | $39.1M | $31.7M | $39.2M | $50.7M | |
Total Debt | $583.9M | $466.3M | $472.4M | $483.2M | $455.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $53.7M | $30.5M | $18.8M | $31.4M | $31.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $93.2M | $96M | $114M | $125.7M | $131M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $10M | $8.5M | $11.4M | $12.5M | $11.9M | |
Other Current Assets | $1.3M | $3.4M | $409K | $7.6M | $8.4M | |
Total Current Assets | $158.2M | $138.4M | $144.7M | $177.2M | $182.7M | |
Property Plant And Equipment | $43.5M | $42.9M | $45.7M | $43.4M | $36.5M | |
Long-Term Investments | $20.6M | $21.5M | -- | $20.5M | -- | |
Goodwill | -- | $101.8M | $102.9M | $146.1M | $165.2M | |
Other Intangibles | $813.5M | $764.6M | $687.9M | $647.3M | $571M | |
Other Long-Term Assets | -- | -- | $21.1M | -- | $26.9M | |
Total Assets | $1B | $1.1B | $1B | $1.1B | $1.1B | |
Accounts Payable | $22.9M | $16.8M | $17.4M | $25.6M | $29.4M | |
Accrued Expenses | $58.6M | $58.6M | $62.1M | $65.8M | $53.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $98.4M | $95.8M | $107.3M | $109.4M | $111M | |
Long-Term Debt | $524.3M | $499.2M | $438.7M | $473.8M | $455.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $689.8M | $673.1M | $617.2M | $661.7M | $593.8M | |
Common Stock | $685K | $698K | $668K | $662K | $637K | |
Other Common Equity Adj | -$5.6M | -$800K | -- | $213K | -$2.1M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $346M | $396.1M | $385M | $481.5M | $489.9M | |
Total Liabilities and Equity | $1B | $1.1B | $1B | $1.1B | $1.1B | |
Cash and Short Terms | $53.7M | $30.5M | $18.8M | $31.4M | $31.4M | |
Total Debt | $532M | $509.4M | $454.2M | $473.8M | $455.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$817.1M | $10.8M | $17.2M | $118.4M | $48.2M | |
Depreciation & Amoritzation | $113.3M | $101.9M | $94.4M | $101M | $107.2M | |
Stock-Based Compensation | $15.2M | $21.4M | $22.3M | $28.5M | $30.6M | |
Change in Accounts Receivable | $3.7M | -$5.4M | -$9.3M | -$15.6M | -$12.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $138.6M | $138M | $128.5M | $136.7M | $152.5M | |
Capital Expenditures | $16.7M | $19.2M | $19.7M | $20.9M | $24.4M | |
Cash Acquisitions | -- | -$20.3M | -$64.7M | -$76.2M | -$216K | |
Cash From Investing | -$16.7M | -$39.5M | -$84.4M | -$97.1M | -$24.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $565M | -- | $45M | $45M | -- | |
Long-Term Debt Repaid | -$615.6M | -$120M | -$41.3M | -$36.3M | -$30M | |
Repurchase of Common Stock | -- | -- | -$49M | -$31.3M | -$49.2M | |
Other Financing Activities | -$17.3M | -$9K | -- | -- | -$29.3M | |
Cash From Financing | -$67.7M | -$127.2M | -$51.5M | -$31.7M | -$116M | |
Beginning Cash (CF) | $13.5M | $67.7M | $39.1M | $31.7M | $39.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $54.2M | -$28.7M | -$7.4M | $7.9M | $12M | |
Ending Cash (CF) | $67.7M | $39.1M | $31.7M | $39.2M | $50.7M | |
Levered Free Cash Flow | $121.9M | $118.8M | $108.8M | $115.8M | $128.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $5.3M | $4.3M | $11.5M | $784K | -$2M | |
Depreciation & Amoritzation | $25.7M | $24.6M | $24M | $27.4M | $27M | |
Stock-Based Compensation | $5M | $5.2M | $6M | $7.1M | $8.3M | |
Change in Accounts Receivable | $282K | $4.4M | -$6.6M | -$1.2M | $2.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $50.4M | $30.4M | $28.1M | $33.5M | $29.5M | |
Capital Expenditures | $6.2M | $4M | $5.4M | $6M | $5.8M | |
Cash Acquisitions | -- | -$64.8M | -- | -- | -$24.4M | |
Cash From Investing | -$6.2M | -$68.8M | -$5.4M | -$6M | -$20.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $45M | -- | -- | $10M | |
Long-Term Debt Repaid | -$52.5M | -$2.5M | -$18.8M | -$10M | -$10M | |
Repurchase of Common Stock | -- | -$5M | -$7.1M | -$9.1M | -$21.5M | |
Other Financing Activities | -$8K | -- | -- | -$7.8M | -- | |
Cash From Financing | -$58.1M | $29.8M | -$35.6M | -$35.2M | -$27.4M | |
Beginning Cash (CF) | $67.7M | $39.1M | $31.7M | $39.2M | $50.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -$87K | -$570K | |
Additions / Reductions | -$14M | -$8.6M | -$12.9M | -$7.7M | -$18.7M | |
Ending Cash (CF) | $53.7M | $30.5M | $18.8M | $31.4M | $31.4M | |
Levered Free Cash Flow | $44.1M | $26.4M | $22.8M | $27.5M | $23.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$24.4M | $9.9M | $24.3M | $107.7M | $45.4M | |
Depreciation & Amoritzation | $108M | $100.8M | $93.9M | $104.3M | $106.9M | |
Stock-Based Compensation | $18.2M | $21.7M | $23.1M | $29.6M | $31.8M | |
Change in Accounts Receivable | -$1.1M | -$1.2M | -$20.3M | -$10.2M | -$8.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $160.1M | $118M | $126.3M | $142M | $148.5M | |
Capital Expenditures | $17.2M | $17M | $21.1M | $21.5M | $24.2M | |
Cash Acquisitions | -- | -$85M | $107K | -$76.2M | -$24.6M | |
Cash From Investing | -$17.2M | -$102M | -$21M | -$97.7M | -$39.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $400M | $45M | -- | -- | -- | |
Long-Term Debt Repaid | -$654.7M | -$70M | -$57.5M | -$27.5M | -$30M | |
Repurchase of Common Stock | -- | -$5M | -$51.1M | -$33.3M | -$61.6M | |
Other Financing Activities | -$17.4M | -- | -- | -- | -- | |
Cash From Financing | -$276.5M | -$39.3M | -$116.9M | -$31.3M | -$108.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$133.6M | -$23.3M | -$11.6M | $13.1M | $1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $142.9M | $101M | $105.2M | $120.5M | $124.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $5.3M | $4.3M | $11.5M | $784K | -$2M | |
Depreciation & Amoritzation | $25.7M | $24.6M | $24M | $27.4M | $27M | |
Stock-Based Compensation | $5M | $5.2M | $6M | $7.1M | $8.3M | |
Change in Accounts Receivable | $282K | $4.4M | -$6.6M | -$1.2M | $2.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $50.4M | $30.4M | $28.1M | $33.5M | $29.5M | |
Capital Expenditures | $6.2M | $4M | $5.4M | $6M | $5.8M | |
Cash Acquisitions | -- | -$64.8M | -- | -- | -$24.4M | |
Cash From Investing | -$6.2M | -$68.8M | -$5.4M | -$6M | -$20.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $45M | -- | -- | $10M | |
Long-Term Debt Repaid | -$52.5M | -$2.5M | -$18.8M | -$10M | -$10M | |
Repurchase of Common Stock | -- | -$5M | -$7.1M | -$9.1M | -$21.5M | |
Other Financing Activities | -$8K | -- | -- | -$7.8M | -- | |
Cash From Financing | -$58.1M | $29.8M | -$35.6M | -$35.2M | -$27.4M | |
Beginning Cash (CF) | $67.7M | $39.1M | $31.7M | $39.2M | $50.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -$87K | -$570K | |
Additions / Reductions | -$14M | -$8.6M | -$12.9M | -$7.7M | -$18.7M | |
Ending Cash (CF) | $53.7M | $30.5M | $18.8M | $31.4M | $31.4M | |
Levered Free Cash Flow | $44.1M | $26.4M | $22.8M | $27.5M | $23.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.